Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-fluorouracil for keloid scarring
2011-000626-29Phase 4Terminated
- Sponsor
- Queen Mary University of London
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fluorouracil in keloid (2 arms), sponsored by Queen Mary University of London. Primary endpoint: Improving the treatment outcomes of keloid scarring. Started Oct 2011; status: terminated.
02
Drugs
fluorouracil
03
Conditions
keloid
Beyond the preview
Go deeper on 2011-000626-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000626-29.